Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: TAKARA BIO USA, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-06-27 to 2024-12-31
Current total value of award: $35231.7
Description: SMARTSCRIBE REVERSE TRANSCRIPTASE AND SEQAMP DNA KITS